ARTL vs IDXX · $15.6M cap vs P/E 40, rev $2.36B
Artelo Biosciences Inc (ARTL) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Artelo Biosciences Inc (ARTL) is a biotechnology company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
ARTL does not have a complete income-statement cache yet.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
ARTL currently screens at market cap $15.6M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the ARTL and IDXX stock pages for the full models.
Not investment advice.